Development & Analytical Strategies for a Novel Editing Technology
Time: 9:30 am
day: Conference Day Two
Details:
- Discussing the development and potential applications of CRISPR-based epigenetic editing technologies, including the EPI 321 program
- Detailing the creation and validation of analytical assays for epigenetic editing, focusing on off-target and on-target analysis, potency assays, and delivery modalities
- Sharing insights on the journey from initial research and development to achieving IND and CTA approvals, highlighting key challenges and successful strategies
